# Fukuzyu Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de

> Inspection records and compliance data for Fukuzyu Pharmaceutical Co., Ltd. in Toyama, None. Access full analysis and detailed observations.

---

## Details

- Name: Fukuzyu Pharmaceutical Co., Ltd.
- FEI Number: 3002807025
- City: Toyama
- State: None
- Country Name: Japan
- Address Line 1: 48, Hagihara
- Zip Code: None

## Related Documents

- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/5552dead-02ee-43ee-aad8-8c303db1c886) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/1552c541-65a5-480e-a82d-3e626e7926fc) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/e878825f-e643-4f5f-b80f-b1c5a17ded54) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/54bf00d2-fc48-4c9c-83e5-fe68cc3518e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/93641215-c512-4196-9f47-79b91c537faa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2025
- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/66552528-7f7e-40bd-b48e-8d2fbc441945) — source: FDA, date: January 19, 2024
- [FDA Inspection 1228860 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/13d1f747-4859-46c8-bfa1-2870be8dfdc1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2024
- [FDA Inspection 1228860 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/1a568251-7ac7-43f1-9209-19a4f2acbb1a) — classification: Official Action Indicated (OAI), source: FDA, date: January 19, 2024
- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-15](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/7079954a-4964-4e3c-9ed4-b2b9dfd957dc) — source: FDA, date: January 15, 2024
- [FDA Inspection 980722 - Fukuzyu Pharmaceutical Co., Ltd. - 2016-07-28](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/0260f99e-5bea-462e-8fa3-71ec3afdea04) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 28, 2016
- [FDA Inspection 826382 - Fukuzyu Pharmaceutical Co., Ltd. - 2013-03-15](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/3382ff37-2805-403d-ae9f-d824dcac2e22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2013

## Related Companies

- [Kyowa Hakko Bio Co., Ltd.](https://www.keypedia.com/companies/kyowa-hakko-bio-co-ltd/4ab0756a-78b6-4060-8087-809db6e7941b)
- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.keypedia.com/companies/alps-pharmaceutical-industrial-co-ltd/b7368086-4ecc-4cbe-b942-494bb1340c79)
- [Bioiberica, SAU](https://www.keypedia.com/companies/bioiberica-sau/3984e671-30b1-4c37-b603-0e20b5a76b7d)
- [Zhejiang Ruibang Laboratories Co., Ltd](https://www.keypedia.com/companies/zhejiang-ruibang-laboratories-co-ltd/d492de6c-b477-4077-b11f-1b6185504623)
- [Smithfield Bioscience Inc](https://www.keypedia.com/companies/smithfield-bioscience-inc/f87613b8-a59a-4a6d-b412-9f2b145f397b)
- [Grant Industries,  Inc.](https://www.keypedia.com/companies/grant-industries-inc/bf60053c-0aa3-4217-b068-ef8b06b6bd27)
- [CTX Lifesciences Private Ltd.](https://www.keypedia.com/companies/ctx-lifesciences-private-ltd/cbf6df36-d316-40a9-891a-10cbbb4e757f)
- [Sionc Pharmaceuticals Private Limited](https://www.keypedia.com/companies/sionc-pharmaceuticals-private-limited/24c737f1-e449-4957-ad35-1990c5d68e2d)
- [SRI Krishna Pharmaceuticals Ltd - Unit I](https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151)
- [Tayca Corporation](https://www.keypedia.com/companies/tayca-corporation/46216ddd-c2d8-492b-bbc2-7011e93a98bf)

## Related Officers

- [Senior Managing Director](https://www.keypedia.com/people/tetsuaki-nishinaga/0caddce5-a415-4f29-abab-433caf9290db)
- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)
- [Nibin Varghese](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)